TY - JOUR AU - Kohler, Jillian Clare AU - Mackey, Tim Ken AU - Ovtcharenko, Natalia PY - 2014 DA - 2014/01/21 TI - Why the MDGs need good governance in pharmaceutical systems to promote global health JO - BMC Public Health SP - 63 VL - 14 IS - 1 AB - Corruption in the health sector can hurt health outcomes. Improving good governance can in turn help prevent health-related corruption. We understand good governance as having the following characteristics: it is consensus-oriented, accountable, transparent, responsive, equitable and inclusive, effective and efficient, follows the rule of law, is participatory and should in theory be less vulnerable to corruption. By focusing on the pharmaceutical system, we explore some of the key lessons learned from existing initiatives in good governance. As the development community begins to identify post-2015 Millennium Development Goals targets, it is essential to evaluate programs in good governance in order to build on these results and establish sustainable strategies. This discussion on the pharmaceutical system illuminates why. SN - 1471-2458 UR - https://doi.org/10.1186/1471-2458-14-63 DO - 10.1186/1471-2458-14-63 ID - Kohler2014 ER -